{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T01:05:03Z","timestamp":1776128703196,"version":"3.50.1"},"reference-count":21,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2001,12,24]],"date-time":"2001-12-24T00:00:00Z","timestamp":1009152000000},"content-version":"vor","delay-in-days":602,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Artificial Organs"],"published-print":{"date-parts":[[2000,5]]},"abstract":"<jats:p><jats:bold>Abstract:<\/jats:bold> Administration of adequate amounts of commercial infusion fluids renders modern convective dialysis modalities, such as hemodiafiltration, labor\u2010intensive and costly. Preparation of infusate by cold sterilization of dialysis fluid, which is abundantly available, and its immediate (online) use, in contrast, enables a large volume fluid exchange in a cost\u2010effective manner. Recent developments aimed at more hygienic and user\u2010friendly online systems with increased operational flexibility. As a result the novel ONLINEplus system does not only provide online prepared infusate for convective dialysis therapy, but also for priming and rinsing of the extracorporeal blood circuit, for intradialytic bolus administration, and for re\u2010infusion of patients' blood as well. Production of infusate from potentially impure dialysis fluid containing endotoxins and other pyrogens raises severe concerns of affecting the patients' well\u2010being. To assess its safety, the online system was challenged with microbially contaminated dialysis fluid. Despite high levels of microbial counts (7.5 \u00d7 10<jats:sup>4<\/jats:sup>\u00b1 10<jats:sup>5<\/jats:sup> CFU\/ml), endotoxin concentration (14.1 \u00b1 7.7 IU\/ml and 9.265 \u00b1 3.000 IU\/ml, as measured turbidimetrically and chromogenically, respectively) and cytokine\u2010inducing activity (20,827 \u00b1 3,082 pg IL\u20101Ra\/Mio WBC), we failed to detect contaminants in the final infusate during a 5 week laboratory testing period. In addition, infusate samples complied consistently with the European Pharmacopeia test for sterility. The present online system is comprehensive, operates user\u2010friendly, and provides microbiologically safe infusate in large quantities. In this way, both patients and dialysis staff will benefit from improved dialysis therapy and reduced treatment\u2010related labor burden, respectively. Moreover, convective dialysis modalities will become less expensive.<\/jats:p>","DOI":"10.1046\/j.1525-1594.2000.06494.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T03:10:53Z","timestamp":1047352253000},"page":"323-328","source":"Crossref","is-referenced-by-count":22,"title":["Novel Online Infusate\u2010Assisted Dialysis System Performs Microbiologically\u2003Safely"],"prefix":"10.1111","volume":"24","author":[{"given":"Christoph","family":"Weber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Groetsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Schlotter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regina","family":"Mitteregger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dieter","family":"Falkenhagen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,24]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1159\/000424220"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/13.2.361"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1999.00236.x"},{"key":"e_1_2_7_5_2","unstructured":"European Pharmacopoeia Third Edition 1997: 2.6.1. Sterility 21\u201325."},{"key":"e_1_2_7_6_2","unstructured":"European Pharmacopoeia Third Edition 1997: 2.6.12. Microbial contamination of products not required to comply with the test for sterility (total viable aerobic count) 83\u201387."},{"key":"e_1_2_7_7_2","unstructured":"European Pharmacopoeia Third Edition 1997 Supplement 1998: 2.6.14. Bacterial endotoxins 29\u201337."},{"key":"e_1_2_7_8_2","unstructured":"Swedish Pharmacopoeia.L\u00e4kemedelsstandard f\u00f6r Finland och Sverige1997 269\u201388."},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1594.1990.tb01601.x"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002480-199410000-00019"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/13.4.949"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1992.105"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.1998.v31.pm9428458"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.1998.v32.pm9669431"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(97)90117-7"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1998.00981.x"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1159\/000189582"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1992.436"},{"key":"e_1_2_7_19_2","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1681\/ASN.V7102183","article-title":"Transmembrane passage of cytokine\u2010inducing bacterial products across new and reprocessed polysulfone dialyzers.","volume":"7","author":"Sundaram S","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1995.72"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1159\/000170238"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002480-199809000-00056"}],"container-title":["Artificial Organs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1525-1594.2000.06494.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1525-1594.2000.06494.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T08:19:57Z","timestamp":1698567597000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1525-1594.2000.06494.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,5]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2000,5]]}},"alternative-id":["10.1046\/j.1525-1594.2000.06494.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1525-1594.2000.06494.x","archive":["Portico"],"relation":{},"ISSN":["0160-564X","1525-1594"],"issn-type":[{"value":"0160-564X","type":"print"},{"value":"1525-1594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,5]]}}}